344 related articles for article (PubMed ID: 25120851)
21. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts.
Saito M; Schetter AJ; Mollerup S; Kohno T; Skaug V; Bowman ED; Mathé EA; Takenoshita S; Yokota J; Haugen A; Harris CC
Clin Cancer Res; 2011 Apr; 17(7):1875-82. PubMed ID: 21350005
[TBL] [Abstract][Full Text] [Related]
22. Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.
Kim MK; Jung SB; Kim JS; Roh MS; Lee JH; Lee EH; Lee HW
Virchows Arch; 2014 Oct; 465(4):463-71. PubMed ID: 25124149
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.
Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W
Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557
[TBL] [Abstract][Full Text] [Related]
26. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
27. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
Chu G; Zhang J; Chen X
J Drug Target; 2016 Aug; 24(7):613-7. PubMed ID: 26581116
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer.
Wang X; Meng X; Li H; Liu W; Shen S; Gao Z
Clin Transl Oncol; 2014 Nov; 16(11):954-8. PubMed ID: 24696291
[TBL] [Abstract][Full Text] [Related]
29. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
30. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.
Xu X; Zhu S; Tao Z; Ye S
Cancer Med; 2018 Jan; 7(1):21-31. PubMed ID: 29266846
[TBL] [Abstract][Full Text] [Related]
31. MiR-519a functions as a tumor suppressor and is negatively associated with poor prognosis of non-small cell lung cancer.
Wang Y; Jiang F; Wang J; Fu Y; Li Y; Li F
Cancer Biomark; 2020; 28(1):121-128. PubMed ID: 32224524
[TBL] [Abstract][Full Text] [Related]
32. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
Zhu J; Zhang Y; Yang X; Jin L
Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.
Tang R; Liang L; Luo D; Feng Z; Huang Q; He R; Gan T; Yang L; Chen G
Med Sci Monit; 2015 Aug; 21():2514-20. PubMed ID: 26305739
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin.
Zhang J; Xu L; Yang Z; Lu H; Hu D; Li W; Zhang Z; Liu B; Ma S
Clin Transl Oncol; 2015 Mar; 17(3):209-14. PubMed ID: 25214146
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
Lin L; Gu ZT; Chen WH; Cao KJ
Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
[TBL] [Abstract][Full Text] [Related]
36. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance.
Shi YK; Zang QL; Li GX; Huang Y; Wang SZ
J Cancer Res Ther; 2016; 12(2):693-8. PubMed ID: 27461635
[TBL] [Abstract][Full Text] [Related]
39. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
